Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor

A. W. Stitt, S. J. Hughes, P. Canning, O. Lynch, O. Cox, N. Frizzell, S. R. Thorpe, T. G. Cotter, T. M. Curtis, T. A. Gardiner

Research output: Contribution to journalArticlepeer-review

56 Citations (Scopus)


AIMS/HYPOTHESIS: Premature death of retinal pericytes is a pathophysiological hallmark of diabetic retinopathy. Among the mechanisms proposed for pericyte death is exposure to AGE, which accumulate during diabetes. The current study used an in vitro model, whereby retinal pericytes were exposed to AGE-modified substrate and the mechanisms underlying pericyte death explored. METHODS: Pericytes were isolated from bovine retinal capillaries and propagated on AGE-modified basement membrane (BM) extract or non-modified native BM. The extent of AGE modification was analysed. Proliferative responses of retinal pericytes propagated on AGE-modified BM were investigated using a 5-bromo-2-deoxy-uridine-based assay. The effect of extrinsically added platelet-derived growth factor (PDGF) isoforms on these proliferative responses was also analysed alongside mRNA expression of the PDGF receptors. Apoptotic death of retinal pericytes grown on AGE-modified BM was investigated using terminal deoxynucleotidyl transferase-mediated dUTP nick end-labelling labelling, mitochondrial membrane depolarisation and by morphological assessment. We also measured both the ability of PDGF to reverse Akt dephosphorylation that was mediated by AGE-modified BM, and increased pericyte apoptosis. RESULTS: Retinal pericytes exposed to AGE-modified BM showed reduced proliferative responses in comparison to controls (p
Original languageUndefined/Unknown
Pages (from-to)1735-1746
Number of pages12
Issue number10
Publication statusPublished - 01 Oct 2004

Bibliographical note

LR: 20121115; GR: DK 19971/DK/NIDDK NIH HHS/United States; JID: 0006777; 0 (Glycosylation End Products, Advanced); 0 (Platelet-Derived Growth Factor); 0 (Proto-Oncogene Proteins c-sis); 0 (platelet-derived growth factor BB); 2004/03/22 [received]; 2004/06/01 [accepted]; 2004/10/22 [aheadofprint]; ppublish


  • Animals
  • Basement Membrane/physiology
  • Cattle
  • Cell Survival/drug effects
  • Glycosylation End Products, Advanced/metabolism
  • Pericytes/physiology
  • Platelet-Derived Growth Factor/pharmacology
  • Proto-Oncogene Proteins c-sis
  • Retina/cytology/physiology
  • Retinal Vessels/cytology/physiology
  • Signal Transduction/drug effects/physiology

Cite this